(Press-News.org) Reston, VA (September 23, 2024)—More than 300 nuclear medicine clinicians, researchers, technologists, regulators and suppliers gathered in Bethesda, Maryland, on September 19-21, for the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 Therapeutics Conference. As the largest SNMMI Therapeutics Conference to date, the meeting offered attendees the chance to explore the latest innovations and advancements in theranostics and other nuclear medicine therapies as well as gain valuable insights into enhancing their practice.
This year’s Therapeutics Conference included eight distinct sessions covering advances in radiopharmaceutical therapies. Several sessions focused on disease-specific therapies, including pediatric therapies, prostate cancer, thyroid diseases, and neuroendocrine tumors, while others addressed issues related to dosimetry, access, supply chain, clinical trials, and research. The conference also included a pre-meeting workshop on streamlining collaborations for study start-ups, a dosimetry hands-on open house, and multiple industry satellite symposia.
“There is so much excitement surrounding theranostics and nuclear medicine therapy, and the SNMMI Therapeutics Conference provided the perfect platform for key players in the field to share and learn from each other,” said Cathy Sue Cutler, PhD, FSNMMI, president of SNMMI.
The conference was organized and moderated by Phillip Koo, MD, Banner MD Anderson Cancer Center, and Hossein Jadvar, MD, PhD, University of Southern California. Attendees appreciated the participation of 34 radiopharmaceutical therapy companies in the exhibit hall, offering attendees the chance to converse directly with industry professionals.
“SNMMI has fostered nuclear medicine therapies and theranostics since the society was founded in 1953,” said Cutler. “From education to clinical trials to standards and guidelines, SNMMI aims to provide nuclear medicine and other medical professionals with the resources necessary to advance theranostics and improve patient care.”
The 2025 SNMMI Therapeutics Conference will be held in Fall 2025. For more information on SNMMI’s resources and activities to support theranostics, visit www.snmmi.org/therapy.
###
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging and theranostics—vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect nuclear medicine research and practice. For more information, visit www.snmmi.org.
END
Advances in theranostics take center stage at SNMMI 2024 Therapeutics Conference
2024-09-23
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Firms that withdrew from Russia following Ukraine invasion earn higher consumer sentiment
2024-09-23
Following Russia’s 2022 invasion of Ukraine, many companies with operations in Russia withdrew from or severely curtailed their Russian operations. For example, Dell and McDonald’s ceased all operations in Russia after the invasion.
Many experts have argued that the corporate response to the Ukraine war is a striking example of stakeholder capitalism, a model where corporations are responsible for considering the interests of various stakeholders — including employees, customers, communities, governments and the environment — and not just ...
Biologist pioneers increased protein in staple crops, helps alleviate global protein shortage
2024-09-23
A Mississippi State biologist’s groundbreaking research in improving global nutrition and sustainability is featured this week in New Phytologist, a leading plant biology journal.
Ling Li, an associate professor in the MSU Department of Biological Sciences, has spent more than a decade studying rice and soybean crops, with the goal of providing a new strategy for crop improvement to increase protein content. Her work offers a potential solution to combat global protein deficiency, a condition affecting millions, particularly children, contributing to cognitive impairments, stunted growth and susceptibility to diseases like Kwashiorkor, ...
Wayne State University awarded grant to combat microplastics in the Great Lakes
2024-09-23
DETROIT — Wayne State University researchers recently received a grant from the Great Lakes Protection Fund to team with the Huron River Watershed Council, the Cleveland Water Alliance, Buffalo Niagara Waterkeeper and Resource Recycling Systems to help communities combat microplastics in water sources.
The project, “Mobilizing a Great Lakes Microplastic Action Network,” is led by Yongli Wager, Ph.D., associate professor of civil and environmental engineering and director of the Sustainable Water-Environment-Energy Technologies Lab in Wayne State’s College of Engineering. The project’s goal is to create ...
CU Anschutz experts identify key opportunities to strengthen climate education for health care professionals
2024-09-23
Doctors and researchers at the University of Colorado Anschutz Medical Campus published a discussion paper today highlighting key initiatives to help strengthen, train and prepare doctors and health care workers for the impact of climate change on human health.
The paper is published in the National Academy of Medicine Perspectives.
The authors, who come from a diverse background in health care from pediatrics to emergency medicine, and nursing to pharmacy, outline the importance of educating a climate-savvy health care workforce and highlight educational opportunities to fulfill the critical need.
“As climate change increasingly ...
Telemedicine improved doctors’ quality of patient care during COVID pandemic, new study shows
2024-09-23
BINGHAMTON, N.Y. -- Telemedicine actually improves the quality of care and increases physician satisfaction in delivering that care, according to new research from Binghamton University, State University of New York.
We all remember when the COVID-19 lockdown in early 2020 upended the comfort of our daily routines. Businesses were forced to adapt to limited ways of engaging with customers, with varied levels of success.
Lockdown posed a unique challenge for physicians: they couldn’t meet with every patient in person. Telemedicine became not only an alternative but the best option for seeing patients in remote areas or where infection rates ...
DECam confirms that early-universe quasar neighborhoods are indeed cluttered
2024-09-23
Quasars are the most luminous objects in the Universe and are powered by material accreting onto supermassive black holes at the centers of galaxies. Studies have shown that early-Universe quasars have black holes so massive that they must have been swallowing gas at very high rates, leading most astronomers to believe that these quasars formed in some of the densest environments in the Universe where gas was most available. However, observational measurements seeking to confirm this conclusion have thus far yielded conflicting results. Now, a new study using the Dark Energy Camera ...
Kashanchi studying parasite-derived vesicles in babesia virulence and vaccine development
2024-09-23
Fatah Kashanchi, Professor, Virology, School of Systems Biology, College of Science; Director, Laboratory of Molecular Virology, received funding for the study: “Parasite-Derived Vesicles in Babesia virulence and Vaccine Development.”
Babesia is a parasite spread by ticks. If humans contract babesiosis, they can experience influenza-like symptoms, bleeding, and organ failure. The condition is rare and affects fewer than 3,000 people in the United States per year.
Kashanchi will isolate extracellular vesicles (EVs) and utilize them to treat primary monocyte-derived macrophages ...
Pandemic-era babies do not have higher autism risk, finds study
2024-09-23
NEW YORK, NY (Sept. 23, 2024)--Children born during the first year of the pandemic, including those exposed to COVID in utero, were no more likely to screen positive for autism than unexposed or pre-pandemic children, found researchers from Columbia University Vagelos College of Physicians and Surgeons.
The study, published in JAMA Network Open, is the first report on autism risk among pandemic-era children.
“Autism risk is known to increase with virtually any kind of insult to mom during pregnancy, including infection and stress,” says Dani Dumitriu, ...
Influenza infection during pregnancy and risk of seizures in offspring
2024-09-23
About The Study: The results of this cohort study suggest that maternal influenza infection during pregnancy was associated with an increased risk of childhood seizures, especially febrile seizures, but not epilepsy. Further studies are needed to elucidate the mechanisms underlying childhood neurological development.
Corresponding Author: To contact the corresponding author, Ming-Chih Lin, MD, PhD, email mingclin@gmail.com.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.34935)
Editor’s ...
Positive autism screening rates in toddlers born during the COVID-19 pandemic
2024-09-23
About The Study: In this cohort study of 2 groups of children with prenatal pandemic exposure and/or exposure to maternal SARS-CoV-2 infection, neither exposure was associated with greater Modified Checklist for Autism in Toddlers, Revised positivity.
Corresponding Author: To contact the corresponding author, Dani Dumitriu, MD, PhD, email dani.dumitriu@columbia.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.35005)
Editor’s Note: Please ...